Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.
2.

MOC31 immunoreactivity in primary and metastatic carcinoma of the liver. Report of findings and review of other utilized markers.

Proca DM, Niemann TH, Porcell AI, DeYoung BR.

Appl Immunohistochem Mol Morphol. 2000 Jun;8(2):120-5. Review.

PMID:
10937059
3.
4.

Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma.

Varma V, Cohen C.

Adv Anat Pathol. 2004 Sep;11(5):239-49. Review.

PMID:
15322490
5.

Liver stem cells: implications for hepatocarcinogenesis.

Alison MR.

Stem Cell Rev. 2005;1(3):253-60. Review.

PMID:
17142862
6.

Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.

McCluggage WG, Young RH.

Semin Diagn Pathol. 2005 Feb;22(1):3-32. Review.

PMID:
16512597
7.

The use of immunohistochemistry in liver tumors.

Chan ES, Yeh MM.

Clin Liver Dis. 2010 Nov;14(4):687-703. doi: 10.1016/j.cld.2010.10.001. Review.

PMID:
21055690
8.

Pediatric liver tumors.

Reynolds M.

Cancer Treat Res. 2001;109:299-312. Review. No abstract available.

PMID:
11775443
9.

[Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].

Tischoff I, Tannapfel A.

Zentralbl Chir. 2007 Aug;132(4):300-5. Review. German.

PMID:
17724632
10.

Malignant liver tumors.

Suriawinata AA, Thung SN.

Clin Liver Dis. 2002 May;6(2):527-54, ix. Review.

PMID:
12122869
11.

Combined hepatocellular-cholangiocarcinoma (cHCC-CC): a distinct entity.

O'Connor K, Walsh JC, Schaeffer DF.

Ann Hepatol. 2014 May-Jun;13(3):317-22. Review.

12.

Spontaneously occurring hepatocellular neoplasia in adolescent cynomolgus monkeys (Macaca fascicularis).

Reindel JF, Walsh KM, Toy KA, Bobrowski WF.

Vet Pathol. 2000 Nov;37(6):656-62. Review.

PMID:
11105957
13.

Current concepts in the immunohistochemical evaluation of liver tumors.

Koehne de Gonzalez AK, Salomao MA, Lagana SM.

World J Hepatol. 2015 Jun 8;7(10):1403-11. doi: 10.4254/wjh.v7.i10.1403. Review.

14.

Tissue Biomarkers in Hepatocellular Tumors: Which, When, and How.

Di Tommaso L, Roncalli M.

Front Med (Lausanne). 2017 Feb 23;4:10. doi: 10.3389/fmed.2017.00010. eCollection 2017. Review.

Supplemental Content

Support Center